WHO Global Coordination Mechanism COPENHAGEN, DENMARK on the Prevention and Control 9–11 APRIL of Noncommunicable Diseases Global Dialogue on Partnerships for Sustainable Financing of NCD Prevention and Control MEETING REPORT WHO/NMH/NMA/GCM/19.01 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Global Dialogue on Partnerships for Sustainable Financing of NCD Prevention Control. Meeting report, Copenhagen, Denmark, 9–11 April 2018. Geneva: World Health Organization; 2019 (WHO/NMH/NMA/GCM/19.01). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/ bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. The contents of this publication do not necessarily reflect the views of any Global Dialogue partner organization, OECD member countries, or the European Commission. ACKNOWLEDGEMENTS This report was made possible thanks to the support and contribution of many individuals from the World Health Organization’s Noncommunicable Diseases and Mental Health Cluster and the colleagues from all WHO regional offices, Government of Denmark and partner organizations. Special thanks are due to the co-chairs and members of the Global Dialogue Steering, Programme and Advisory Committees for their intellectual support and strategic guidance: Bente Mikkelsen, Birgitte Mossin Bronden, Téa Collins, Katie Dain, Bent Lautrup-Nielsen, Nick Banatvala, Douglas Bettcher, Francesco Branca, Vanessa Candeias, Annie Chu, Guy Fones, Paul Garwood, Sophie Genay-Diliautas, Marta Guglielmetti, Asmus Hammerich, Anselm Hennis, Gitte Hundahl, Priya Kanayson, Etienne Krug, Alexey Kulikov, Grega Kumer, Mary-Anne Land, Lina Mahy, Daniel Míc, Line Neerup Handlos, James Pfitzer, Marge Reinap, Dag Rekve, Shekhar Saxena, Hai-Rai Shin, Steven Shongwe, Slim Slama, Thaksaphon Thamarangsi, Menno Van Hilten, Tatiana Vorovchenko. Overall guidance was provided by Svetlana Akselrod. Téa Collins acted as principle drafter of this report and oversaw the development and design of the document with technical support by Ayodele Akinnawo. Warm thanks are extended to the WHO GCM/NCD participants, including dialogue and working group co-chairs, members, and special advisers for their participation and valuable expertise ensuring a successful Global Dialogue meeting. Significant technical and financial contributions made by the World Diabetes Foundation, World Economic Forum, NCD Alliance, International Federation of Pharmaceutical Manufacturers & Associations and Organisation for Economic Co-operation and Development are gratefully acknowledged. Editorial support was provided by John Dawson. Art Direction and Design: Human After All. CONTENTS Foreword 6 1. Global Dialogue: overview 8 2. Daily programme of the Global Dialogue 10 Day 1 14 Opening ceremony 14 Plenary session 1. Setting the stage: the role of partnerships 19 and innovative financing to accelerate national NCD responses Plenary session 2. Development cooperation for NCDs: aligning and 21 leveraging domestic and external resources to achieve SDG target 3.4 Day 2 26 Plenary session 3. Exploring synergies between financing national NCD 26 responses and broader health systems strengthening efforts for universal health coverage: launch of the report of the Lancet Taskforce on NCDs and economics Plenary session 4. Summary of key outcomes 29 Day 3 29 Plenary session 5. Synthesis: summary, conclusion 29 and recommendations Plenary session 6. Multistakeholder and multisectoral action: 34 a means to unlock financing for NCDs Programme of meeting 37 3. Global Dialogue outcomes 48 3.1 High-level summary 50 3.2 Copenhagen Global Dialogue recommendations for accelerating 52 national NCD responses The role of partnerships and innovative financing to accelerate national 52 NCD responses Development cooperation for NCDs: aligning and leveraging external 52 and domestic resources to achieve SDG target 3.4 Exploring synergies between financing national NCD responses 54 and broader health systems strengthening efforts for universal health coverage 4 | WHO – Copenhagen Report CONTENTS 3.3 Key messages from multistakeholder and multisectoral dialogue 55 and partnership forums Parallel session 2.1. Mobilizing resources for a joint United Nations system 55 response to NCDs: the role of development cooperation Parallel session 2.2. Mobilizing domestic resources for NCDs: learning from 55 country experiences Parallel session 2.3. How to harness the power of the private sector 56 to implement national NCD responses Parallel session 2.4. Measuring resource flows into NCDs: current trends 56 and projections Parallel session 3.1. Political economy of universal health coverage for NCDs: 56 what are the necessary economic, social and political preconditions to make universal health coverage for NCDs a realistic goal for all? Parallel session 3.2. Investing in innovative service delivery models towards 56 integrated person-centred care for NCDs Parallel session 3.3. Building the investment case for NCD prevention 57 and control Parallel session 3.4. Cost-effective and feasible solutions: WHO “best buys” 57 Partnership forum 1. Scaling up digital health for NCDs: 57 leaving no one behind Partnership forum 2. NCDs and mental health in emergencies: 57 beyond current financing Partnership forum 3. A vital investment: scaling up health workforce for NCDs 58 Partnership forum 4. Accelerating access to medicines and new technologies 58 in low- and middle-income countries: viable models for innovative partnerships Partnership forum 5. Advocacy for resource mobilization for NCDs: 58 the role of civil society for holding stakeholders accountable Partnership forum 6. Creating a shared value: aligning commercial 58 and public health interests to tackle NCDs 4. Annexes 60 Annex 1. Plenary speeches and presentations 62 Annex 2. Participants and listings 65 Annex 3. Image gallery 98 5 Foreword It is well known that noncommunicable diseases (NCDs), such to overcome the NCD epidemic. WHO recognizes the need for as cardiovascular diseases, cancers, chronic obstructive lung urgent action. This is why, in the lead-up to the third High-level disease and diabetes, are affecting millions of people worldwide, Meeting on the Prevention and Control of NCDs, the prematurely taking lives at all stages of the life course from very Government of Denmark and the WHO Global Coordination young to old age. It is also common knowledge that over three Mechanism on the Prevention and Control of NCDs (GCM/ quarters of these deaths occur in low- and middle-income NCD) co-organized a Global Dialogue on Partnerships for countries, many of which continue to struggle with devastating Sustainable Financing of NCD Prevention and Control from